Clear Harbor Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Clear Harbor Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Hold	8,799	–	–	0.13%	130
2026 Q1	$1.77M	Buy	8,799 +352	+4%	+$72.8K	0.12%	139
2025 Q4	$1.74M	Buy	8,447 +160	+2%	+$32K	0.12%	138
2025 Q3	$1.49M	Buy	8,287 +155	+2%	+$26.4K	0.1%	156
2025 Q2	$1.31M	Sell	8,132 -501	-6%	-$79.8K	0.1%	159
2025 Q1	$1.47M	Buy	8,633 +15	+0.2%	+$2.6K	0.12%	131
2024 Q4	$1.43M	Sell	8,618 -90	-1%	-$15.4K	0.11%	135
2024 Q3	$1.5M	Buy	8,708 +15	+0.2%	+$2.48K	0.12%	127
2024 Q2	$1.34M	Sell	8,693 -1,010	-10%	-$152K	0.11%	135
2024 Q1	$1.49M	Sell	9,703 -320	-3%	-$48.8K	0.13%	126
2023 Q4	$1.58M	Sell	10,023 -1,288	-11%	-$185K	0.15%	120
2023 Q3	$1.66M	Sell	11,311 -27	-0.2%	-$4.11K	0.17%	108
2023 Q2	$1.74M	Sell	11,338 -245	-2%	-$38.2K	0.17%	111
2023 Q1	$1.8M	Sell	11,583 -1,051	-8%	-$165K	0.19%	110
2022 Q4	$1.95M	Sell	12,634 -25	-0.2%	-$3.69K	0.24%	85
2022 Q3	$1.67M	Sell	12,659 -220	-2%	-$30.9K	0.23%	82
2022 Q2	$1.75M	Buy	12,879 +100	+0.8%	+$13.8K	0.23%	82
2022 Q1	$1.91M	Sell	12,779 -568	-4%	-$84K	0.22%	88
2021 Q4	$2.16M	Buy	13,347 +278	+2%	+$45K	0.23%	83
2021 Q3	$2.17M	Buy	13,069 +130	+1%	+$22.2K	0.04%	89
2021 Q2	$2.23M	Buy	12,939 +741	+6%	+$122K	0.27%	75
2021 Q1	$1.96M	Buy	12,198 +1,760	+17%	+$301K	0.26%	73
2020 Q4	$1.75M	Buy	10,438 +2,708	+35%	+$439K	0.25%	68
2020 Q3	$1.22M	Sell	7,730 -280	-3%	-$45.8K	0.21%	86
2020 Q2	$1.34M	Buy	8,010 +800	+11%	+$126K	0.25%	79
2020 Q1	$945K	Buy	7,210 +145	+2%	+$20.7K	0.22%	82
2019 Q4	$1.05M	Buy	+7,065	New	+$970K	0.18%	97

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Clear Harbor Asset Management's FBT Position: Q2 2026 in Review

Clear Harbor Asset Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 8,799 shares worth $2.18M. The position accounts for 0.13% of the portfolio, ranked #130.

Clear Harbor Asset Management first reported a position in FBT in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.23M in Q2 2021. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Clear Harbor Asset Management held 8,799 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.18M as of Q2 2026.
Clear Harbor Asset Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.13% of Clear Harbor Asset Management's portfolio in Q2 2026, its #130 holding.
Clear Harbor Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 27 quarters since.
Clear Harbor Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.23M in Q2 2021.
340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.